NCT00035360View on ClinicalTrials.gov

Phase III PEG-Intron in HIV-infected Patients (Study P00738)

PHASE3CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

October 31, 2003

Study Completion Date

October 31, 2003

Conditions
HIV InfectionsAIDS
Interventions
DRUG

PEG-Intron

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00035360 - Phase III PEG-Intron in HIV-infected Patients (Study P00738) | Biotech Hunter | Biotech Hunter